Nothing Special   »   [go: up one dir, main page]

AU2001247887A1 - Dual mechanism timed release dosage forms for low dose drugs - Google Patents

Dual mechanism timed release dosage forms for low dose drugs

Info

Publication number
AU2001247887A1
AU2001247887A1 AU2001247887A AU4788701A AU2001247887A1 AU 2001247887 A1 AU2001247887 A1 AU 2001247887A1 AU 2001247887 A AU2001247887 A AU 2001247887A AU 4788701 A AU4788701 A AU 4788701A AU 2001247887 A1 AU2001247887 A1 AU 2001247887A1
Authority
AU
Australia
Prior art keywords
dosage forms
low dose
release dosage
timed release
dual mechanism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247887A
Inventor
James M. Clevenger
Alfio B. Gallo
Der-Yang Lee
Gopi M. Venkatesh
Krishna S. Vishnupad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adare Pharma Solutions Inc
Original Assignee
Eurand America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand America Inc filed Critical Eurand America Inc
Publication of AU2001247887A1 publication Critical patent/AU2001247887A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001247887A 2000-04-19 2001-03-30 Dual mechanism timed release dosage forms for low dose drugs Abandoned AU2001247887A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55233500A 2000-04-19 2000-04-19
US09552335 2000-04-19
PCT/US2001/010175 WO2001080824A2 (en) 2000-04-19 2001-03-30 Dual mechanism timed release dosage forms for low dose drugs

Publications (1)

Publication Number Publication Date
AU2001247887A1 true AU2001247887A1 (en) 2001-11-07

Family

ID=24204903

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247887A Abandoned AU2001247887A1 (en) 2000-04-19 2001-03-30 Dual mechanism timed release dosage forms for low dose drugs

Country Status (2)

Country Link
AU (1) AU2001247887A1 (en)
WO (1) WO2001080824A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8168218B2 (en) 2003-04-24 2012-05-01 Jagotec Ag Delayed release tablet with defined core geometry
DE102004043863A1 (en) 2004-09-10 2006-03-16 Nitec Pharma Ag Tablets with local and time-controlled drug release in the gastrointestinal tract
US8703191B2 (en) 2006-07-25 2014-04-22 Intelgenx Corp. Controlled-release pharmaceutical tablets
US7674479B2 (en) 2006-07-25 2010-03-09 Intelgenx Corp. Sustained-release bupropion and bupropion/mecamylamine tablets
SG174026A1 (en) 2006-08-03 2011-09-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid disease
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
CN111228229A (en) * 2020-03-31 2020-06-05 鲁南制药集团股份有限公司 Sotalol hydrochloride tablet and preparation process thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
US5593694A (en) * 1991-10-04 1997-01-14 Yoshitomi Pharmaceutical Industries, Ltd. Sustained release tablet
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation

Also Published As

Publication number Publication date
WO2001080824A2 (en) 2001-11-01
WO2001080824A3 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
IL154012A0 (en) Hydrogel-driven drug dosage form
AU2002363360A1 (en) Dual controlled release dosage form
IL150657A0 (en) Multi-step drug dosage forms
AU2002218250A1 (en) Medicament dispenser
AU2002217979A1 (en) Medicine feeder
HUP0301242A3 (en) Controlled release drug dosage form
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU1724301A (en) Hydrogel-driven layered drug dosage form
AU2002223562A1 (en) Medicament dispenser
AU2001247887A1 (en) Dual mechanism timed release dosage forms for low dose drugs
AU2002214006A1 (en) Drugs for diabetes
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
EP1207852A4 (en) Controlled release oral dosage suitable for oral administration
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2001256168A1 (en) Metered dose inhaler
AU4417101A (en) Metered dose inhaler
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
AU4831801A (en) Metered dose inhaler
AU3945501A (en) Apparatus for dosage of medicaments
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU4417001A (en) Metered dose inhaler
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
AU2001248943A1 (en) Pharmaceutical curative compound
AU2002215902A1 (en) Medicament dispenser
AU2001292578A1 (en) Pharmaceutical compounds